Corbus Pharmaceuticals, Inc. is a close-knit team of almost 50 employees who are high-achievers, innovative, creative and, above all else, passionate about what we do. We hire for personality as well as for skill.
You must thrive in an entrepreneurial and autonomous environment where you will succeed based on your contribution and work ethic, not on your title or rank. At Corbus we take pride in our "family" atmosphere where each person's contribution is vital to our success. As a Corbus employee, you are empowered to think creatively and be proactive in your approach. There is no place for politics or red tape here. Positive, team-oriented people work at Corbus and are rewarded with fun perks like weekly food deliveries to our kitchen, a monthly in-house massage therapist and organized company activities and outings. Additionally, Corbus offers an attractive, comprehensive benefit package.
This year, Corbus was named one of the Best Places To Work by Boston Business Journal
Corbus (NASDAQ: CRBP) is a Phase 3 clinical stage specialty pharmaceutical company focused on the development and commercialization of novel therapeutics to treat life threatening ("orphan") inflammatory-fibrotic diseases with clear unmet needs.
Our lead product Anabasum, is an endocannabinoid mimetic (CB2 agonist) that is designed to resolve inflammation and halt fibrosis. The drug recently completed Phase 2 with positive results in cystic fibrosis and systemic sclerosis. We expect to commence a Phase 3 study in systemic sclerosis and a Phase 2B in cystic fibrosis in the fourth quarter of 2017. Phase 2 clinical results in dermatomyositis are expected in the third quarter of 2017 and a Phase 2 trial in systemic lupus erythematosus is expected to comment in the 2nd half of 2017.
Your Career Is Looking Up At Corbus